全文获取类型
收费全文 | 5466961篇 |
免费 | 414656篇 |
国内免费 | 16753篇 |
专业分类
耳鼻咽喉 | 78237篇 |
儿科学 | 173019篇 |
妇产科学 | 145677篇 |
基础医学 | 805688篇 |
口腔科学 | 155663篇 |
临床医学 | 504806篇 |
内科学 | 997566篇 |
皮肤病学 | 125871篇 |
神经病学 | 456551篇 |
特种医学 | 213798篇 |
外国民族医学 | 1455篇 |
外科学 | 815837篇 |
综合类 | 153435篇 |
现状与发展 | 24篇 |
一般理论 | 3038篇 |
预防医学 | 459724篇 |
眼科学 | 130896篇 |
药学 | 393126篇 |
28篇 | |
中国医学 | 14113篇 |
肿瘤学 | 269818篇 |
出版年
2021年 | 57280篇 |
2019年 | 59710篇 |
2018年 | 77427篇 |
2017年 | 59428篇 |
2016年 | 66256篇 |
2015年 | 78171篇 |
2014年 | 113009篇 |
2013年 | 178899篇 |
2012年 | 156140篇 |
2011年 | 166431篇 |
2010年 | 135262篇 |
2009年 | 134110篇 |
2008年 | 151741篇 |
2007年 | 163603篇 |
2006年 | 170164篇 |
2005年 | 164298篇 |
2004年 | 164619篇 |
2003年 | 154092篇 |
2002年 | 143574篇 |
2001年 | 219545篇 |
2000年 | 217958篇 |
1999年 | 194064篇 |
1998年 | 79248篇 |
1997年 | 73101篇 |
1996年 | 70918篇 |
1995年 | 66579篇 |
1994年 | 60578篇 |
1993年 | 55945篇 |
1992年 | 145350篇 |
1991年 | 139872篇 |
1990年 | 134575篇 |
1989年 | 130631篇 |
1988年 | 120914篇 |
1987年 | 118995篇 |
1986年 | 112570篇 |
1985年 | 109412篇 |
1984年 | 87363篇 |
1983年 | 76678篇 |
1982年 | 55189篇 |
1981年 | 50943篇 |
1980年 | 47675篇 |
1979年 | 78473篇 |
1978年 | 60139篇 |
1977年 | 52365篇 |
1976年 | 49025篇 |
1975年 | 49971篇 |
1974年 | 57577篇 |
1973年 | 55234篇 |
1972年 | 51996篇 |
1971年 | 47950篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
W. S. L. Stebbings M. J. G. Farthing J. R. Puddefoot Elizabeth Anderson G. P. Vinson J. M. A. Northover R. F. M. Wood 《Journal of cancer research and clinical oncology》1988,114(2):208-211
Summary To evaluate the potential effect of androgens on the development and growth of human colorectal adenomas, the prevalence and concentration of cytosolic androgen receptors (AR) were analysed in 26 adenomas and 19 samples of normal colonic mucosa by a hybrid ligand receptor-binding assay. AR were detected in 7 of the adenomas (26.9%), and in 6 of the normal mucosa samples (31.6%). In the adenomas, AR levels demonstrated were low, ranging from 6 to 31 fmol/mg cytosol protein, and dissociation constants (Kds) ranged from 0.17–2.7x10-9
M. Of 13 adenomas excised from men, 6 (46%) had positive receptor activity, whereas only 1 of 13 (7.7%) from women was positive (P=0.03, Fisher's exact test). There was no correlation between AR titre and patient age, or between adenoma size and histological type or degree of dysplasia. In normal mucosa, AR levels ranged from 7 to 33 fmol/mg and Kds ranges from 0.24–3.1x10-9
M. There was no significant difference between either AR prevalence or levels in the adenomas and normal mucosa. The sex difference was exclusive to the adenoma. Endogenous androgen may play a role in adenoma development early in the promotional process. 相似文献
993.
994.
Cytokines play a part in the control of cellular growth, differentiation and development. Given such pleiotropic activities, it is not unexpected that the expression of the cytokines is tightly regulated. When cytokine-mediated processes are altered by mutation and/or overexpression of some cytokine or cytokine receptor genes, oncogenic transformation can occur. Oncogenes which derive their transforming potential through this mechanism include sis, which represents the activated form of the platelet-derived growth factor B chain, hst1/K-fgflint-2, which share appreciable homology with the gene family of fibroblast growth factors, fms, which is related to the cell surface receptor for macrophage-colony stimulating factor, and erbB-1, which encodes a truncated form of the epidermal growth factor receptor. Cytokine treatment has resulted in modulation of aberrant oncogene activity in some model systems. 相似文献
995.
996.
百年乐与人参黄芪合剂对心血管系统的药理作用比较 总被引:1,自引:1,他引:0
百年乐和人参黄芪合剂对心血管系统的作用研究表明:百年乐能加速小鼠肠系膜微循环障碍的恢复,增加离体兔耳血管的流量,使主动脉平滑肌松弛,对抗心肌缺氧,抑制血栓形成,其作用强于人参黄芪合剂。 相似文献
997.
998.
Summary Experimental data suggest that multidrug resistance in cancer may be overcome by using an increased dose of anticancer agent(s) in combination with a resistance-modifying agent (RMA). We studied the pharmacokinetics and metabolism of both epirubicin (EPI) and verapamil (VPL) to explore the possible pharmacokinetic interactions between these two drugs. Ten patients with advanced breast cancer were given EPI (40 mg/m2 in a daily i.v. bolus for 3 consecutive days), and five of them also received VPL (4×120 mg/daily p.o. for 4 consecutive days). The data indicated a significant interaction between these two drugs that affected their metabolism. The areas under the concentration-time curves (AUC) obtained for epirubicin glucuronide, epirubicinol glucuronide, and both of the 7-deoxy-aglycones were higher in the EPI+VPL group as compared with the EPI group. The AUC, terminal half-life, mean residence time, volume of distribution at steady state, and plasma clearance of EPI alone as compared with EPI+VPL did not differ significantly. These results suggest either an induction of enzymes necessary for drug metabolism or an increase in the liver blood flow, resulting in an enhanced generation of metabolites with time or in an inhibition of excretion processes. Comparisons of the AUC values obtained for EPI and its metabolites after the first, second, and third injections of EPI revealed a cumulative effect for the metabolites that was more pronounced in the EPI+VPL group, being significant (P<0.05) for epirubicin glucuronide in both treatment groups and for epirubicinol glucuronide in the EPI+VPL group. Maximal concentrations of VPL and nor-VPL reached 705±473 and 308±122 ng/ml, respectively, with the steady-state concentrations being 265±42 ng/ml for VPL and 180±12 ng/ml for nor-VPL.This study was supported by the Erich und Gertrud Roggenbuck-Stiftung zur Förderung der Krebsforschung (Hamburg). The anthracycline metabolites were kindly provided by Dr. A. Suarato (Farmitalia, Milano, Italy); nor verapamil was provided by Dr. Traugott (Knoll, Ludwigshafen, Germany) 相似文献
999.
Angiotensin Converting Enzyme Inhibitors: Animal Experiments Suggest a New Pharmacological Treatment for Alcohol Abuse in Humans 总被引:1,自引:0,他引:1
G. Spinosa MSc E. Perlanski Dipl Tech. F. H. H. Leenen MD R. B. Stewart MSc L. A. Grupp DSc 《Alcoholism, clinical and experimental research》1988,12(1):65-70
The prevalence of heavy alcohol consumption is a major problem of increasing proportions throughout the world. Although alcohol sensitizing drugs and more recently serotonin uptake inhibitors are drug interventions with some following, their long term beneficial consequences have yet to be demonstrated. In recent years, we have demonstrated that manipulating activity in the renin-angiotensin system will dramatically alter voluntary alcohol consumption in rats. Based on these findings, the present study evaluated the ability of a class of drugs known as the angiotensin converting enzyme inhibitors to reduce voluntary alcohol drinking in laboratory animals. These drugs prevent the conversion of angiotensin I to angiotensin II. They have been licensed for use in Europe and North America and are indicated in the treatment of hypertension. Our experiments showed that both captopril (Capoten, Squibb) and enalapril (Vasotec, Merck Sharpe & Dohme) can reduce alcohol drinking in both normotensive and hypertensive animals regardless of whether the pattern of intake is in a bout or of a less exaggerated nature. Furthermore, this change in alcohol intake can occur without concomitant changes in blood pressure, plasma renin activity, overall fluid balance, or the distribution and metabolism of alcohol. Taken together these findings suggest that the angiotensin converting enzyme inhibitors should be evaluated in a clinical setting for they may prove to be a useful new treatment or treatment adjunct for alcohol abuse in humans. 相似文献
1000.